BBI News and Press, Brickell Biotech Inc. From 04/23/21

Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking ...

BOULDER, Colo., April 16, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debil...

BOULDER, Colo., April 15, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debil...

4 Penny Stocks to Watch as Stimulus Checks Roll In Markets were mixed at the open this morning, but it’s been a more bullish trend for penny stocks. In this case, let’s take a look at the Russell 2000 Small-Cap ETF ( NYSE: IWM ). As you’ll see, in tandem with ot...

Gainers: Neos Therapeutics (NEOS) +17%,Aytu BioScience (AYTU) +14%, Vericel (VCEL) +14%, Brickell Biotech (BBI) +14%, Infinity Pharmaceuticals (INFI) +13%.Losers: Translate Bio (TBIO) -32%, ContraFect (CFRX) -13%, Lipocine (LPCN...

BioHiTech Global (BHTG) +44% on receiving $2M in Digester orders.Upstart Holdings (UPST) +39% on Q4 results.Neos Therapeutics (NEOS) +30%.Seneca Biopharma (SNCA) +26%.Evolving Systems (EVOL) +24% on Q4 results.Can-Fite BioPharma (CANF) +17% on announcing new data from a pr...

The following slide deck was published by Brickell Biotech, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Brickell Biotech, Inc. 2020 Q4 - Results - Earnings Call Presentation

Brickell Biotech, Inc. (BBI) Q4 2020 Earnings Conference Call March 09, 2021, 04:30 PM ET Company Participants Dan Ferry - Investor Relations, LifeSci Advisors Robert Brown - Chief Executive Officer Deepak Chadha - Chief R&D Officer Bert Marchio - Chief Financial Officer Andy Sklawer - CO...

BOULDER, Colo., March 05, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today an...

ASLAN Pharmaceuticals Limited (ASLN) +71% as ASLAN004 shows positive effect in atopic dermatitis.Apollo Endosurgery (APEN) +47% after receiving a Breakthrough Device Designation from the USFDA for the Orbera® Intragastric Balloon.electroCore (ECOR) +39% on exclusive distri...